Our top priority is the health and safety of our community. Visit our COVID-19 information page to see how we're responding to the public health emergency.

    DOJOLVI (triheptanoin) is the first and only FDA-approved treatment for children and adults with long-chain fatty acid oxidation disorders (LC-FAOD).

    Chart of LC-FAOD ENZYME DEFICIENTCIES

    WHAT IS DOJOLVI?

    DOJOLVI is a prescription medicine used to treat long-chain fatty acid oxidation disorders (LC-FAOD) in children and adults.

    How does DOJOLVI work?

    • DOJOLVI provides an alternate source of energy. It is a synthetic medium odd-chain 7-carbon triglyceride (C7).
    • DOJOLVI bypasses the enzyme deficiencies that cause LC-FAOD to provide a source of calories and fatty acids that can be converted to energy.

    Talk to your healthcare team to learn more about DOJOLVI.

    DOJOLVI® (triheptanoin) structure - a synthetic medium odd-chain 7-carbon (C7) triglyceride

    WHAT ARE LC-FAOD?

    Long-chain fatty acid oxidation disorders (LC-FAOD) are rare inherited disorders that prevent the body from breaking down long-chain fatty acids into energy during metabolism.

    People living with LC-FAOD have difficulty producing enough energy because of their body’s inability to use long-chain fatty acids as an energy source during times of:

    • Fasting
    • Illness
    • Prolonged exercise

    If you or your loved one are living with one of the different types of LC-FAOD, DOJOLVI may provide an alternative source of energy. Ask your healthcare team if DOJOLVI is right for you.

    STARTING DOJOLVI

    UltraCare® Patient Services is here to help you:

    • Gain access to DOJOLVI
    • Understand your insurance coverage
    • Determine your eligibility for financial and patient assistance programs
    • Utilize patient support program resources

    Visit UltraCare

    A completed Start Form is required for enrollment in UltraCare Patient Services. Talk to your healthcare team.

    Ultracare.com home page on a laptop
    DOJOLVI® (triheptanoin) Dosing Guide Download the Guide

    TAKING DOJOLVI

    Download this step-by-step guide to discuss with your healthcare team how to store, administer, and keep track of DOJOLVI doses.

    Download the Guide

    WORKING WITH YOUR HEALTHCARE TEAM

    Patients treated with DOJOLVI should work with a team of clinical specialists, such as metabolic doctors, dietitians, and nurse practitioners. Your healthcare team may:

    • Start your dose slowly, beginning with a low dose of DOJOLVI and then increasing it over time to help you avoid side effects
    • Manage your diet, checking in regularly and providing you with nutritional plans based on your specific needs

    Important: Stop taking any other medium-chain triglyceride (MCT) products before you begin DOJOLVI.

    Learn more about taking DOJOLVI
    Alexandra Living with LCHAD, a type of LC-FAOD
    Photo of Alexandra, living with LCHAD, a type of LC-FAOD

    “There are going to be challenges, but take it one step at a time. Make sure you’re celebrating the good days and the milestones.”

    Discover Patient Stories
    Alexandra Living with LCHAD, a type of LC-FAOD

    Stay Informed

    Connect with us to get the latest information on LC-FAOD and/or DOJOLVI.

    *Required fields


    What is DOJOLVI?

    DOJOLVI is a prescription medicine used to treat long-chain fatty acid oxidation disorders (LC-FAOD) in children and adults.

    IMPORTANT SAFETY INFORMATION

    Before taking DOJOLVI, tell your healthcare provider about all of your medical conditions, including if you:

    • are pregnant or plan to become pregnant. It is not known if DOJOLVI will harm your unborn baby. Pregnancy Safety Study: There is a pregnancy safety study for women who take DOJOLVI during pregnancy. The purpose of this study is to collect information about your health and your baby's health. You can talk to your healthcare provider or contact 1-888-756-8657 to enroll in this study or get more information.
    • are breastfeeding or plan to breastfeed. It is not known if DOJOLVI passes into breast milk. Talk to your healthcare provider about the best way to feed your baby if you take DOJOLVI.
    • are taking a pancreatic lipase inhibitor, such as orlistat, as it may affect how well DOJOLVI works.

    Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

    What are the possible side effects of DOJOLVI?

    • Feeding tube problems. Feeding tubes may not work as well or stop working over time when taking DOJOLVI. Do not use DOJOLVI in feeding tubes made of polyvinyl chloride (PVC). Check the feeding tube to make sure it is working properly and not breaking down.
    • Intestinal absorption problems in patients with pancreatic insufficiency. If you have pancreatic insufficiency, consult with your healthcare provider as it may affect how well DOJOLVI works.
    • The most common side effects of DOJOLVI include:
      • stomach (abdominal) pain
      • diarrhea
      • vomiting
      • nausea

    These are not all the possible side effects of DOJOLVI. Call your healthcare provider for medical advice about side effects. You may report side effects to Ultragenyx Pharmaceutical Inc. at 1-888-756-8657 or FDA at 1-800-FDA-1088.

    Please see full Prescribing Information, including Patient Information, for additional important safety information and instructions for use.

    LESS -

    What is DOJOLVI?

    DOJOLVI is a prescription medicine used to treat long-chain fatty acid oxidation disorders (LC-FAOD) in children and adults.

    IMPORTANT SAFETY INFORMATION

    Before taking DOJOLVI, tell your healthcare provider about all of your medical conditions, including if you:

    • are pregnant or plan to become pregnant. It is not known if DOJOLVI will harm your unborn baby. Pregnancy Safety Study: There is a pregnancy safety study for women who take DOJOLVI during pregnancy. The purpose of this study is to collect information about your health and your baby's health. You can talk to your healthcare provider or contact 1-888-756-8657 to enroll in this study or get more information.
    • are breastfeeding or plan to breastfeed. It is not known if DOJOLVI passes into breast milk. Talk to your healthcare provider about the best way to feed your baby if you take DOJOLVI.
    • are taking a pancreatic lipase inhibitor, such as orlistat, as it may affect how well DOJOLVI works.

    Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

    What are the possible side effects of DOJOLVI?

    • Feeding tube problems. Feeding tubes may not work as well or stop working over time when taking DOJOLVI. Do not use DOJOLVI in feeding tubes made of polyvinyl chloride (PVC). Check the feeding tube to make sure it is working properly and not breaking down.
    • Intestinal absorption problems in patients with pancreatic insufficiency. If you have pancreatic insufficiency, consult with your healthcare provider as it may affect how well DOJOLVI works.
    • The most common side effects of DOJOLVI include:
      • stomach (abdominal) pain
      • diarrhea
      • vomiting
      • nausea

    These are not all the possible side effects of DOJOLVI. Call your healthcare provider for medical advice about side effects. You may report side effects to Ultragenyx Pharmaceutical Inc. at 1-888-756-8657 or FDA at 1-800-FDA-1088.

    Please see full Prescribing Information, including Patient Information, for additional important safety information and instructions for use.

    MORE +